PHIO (RXi Pharmaceuticals) Prakiraan pendapatan perusahaan

Logo korporat perusahaan Phio Pharmaceuticals Corp. (PHIO)

The key driver for Phio Pharmaceuticals (PHIO) is the INTASYL platform for creating self-delivering RNA interference in immuno-oncology. The company's expected sales volume on the GURU.Markets daily chart reflects the dynamics of this potential, where 0.00 captures the magnitude of this parameter. Preclinical in vivo tests to mitigate risks and the prospects of strategic alliances with the largest pharma behemoths in the untapped niche of precision therapy further strengthen the fundamentals.

PHIO - Prakiraan volume dodolan Phio Pharmaceuticals ing rentang 04.07.2022 - 15.11.2026

Ringkesan rincian data analitis Phio Pharmaceuticals Corp. (PHIO)

- nilai saham lan prakiraan konsensus rega:
Analisis komprehensif perusahaan:Phio Pharmaceuticals Corp. PHIO
Produk merek phiopharma.com

Investors assess an asset's operational resilience through the ratio of market capitalization to expected revenue. For Phio Pharmaceuticals (PHIO), the automation of oligonucleotide synthesis via robotics increases drug development precision, impacting future earnings. By analyzing the company's projected sales volume, you can see the dependence of the current share price on expected cash flows. This metric measures market expectations regarding the commercialization of technologies. The indicator's trend confirms the financial viability of the business model.

Pesaing wigati

Volume dodolan mangsa ngarep perusahaan TEM (Tempus AI)|Dodolan mangsa ngarep perusahaan Qiagen Group|Prakiraan pendapatan perusahaan Ionis Pharma IONS|RGEN - Volume dodolan mangsa ngarep perusahaan|RNA - Prakiraan pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan CRSP (CRISPR Therapeutics AG)|Sema4 (WGS) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan RARE (Ultragenyx)|Volume dodolan mangsa ngarep perusahaan BEAM|Prakiraan volume dodolan Sarepta Corp|Prakiraan pendapatan perusahaan Twist Bioscience, Inc. (TWST)|Volume dodolan mangsa ngarep perusahaan 10x Genomics TXG|Prakiraan pendapatan perusahaan Intellia Therapeutics NTLA|Prakiraan volume pendapatan perusahaan STOK (Stoke Therapeutics, Inc.)|BLFS - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Wave Pharma|mazetx.com (MAZE) - Prakiraan pendapatan perusahaan|SION - Dodolan mangsa ngarep perusahaan|PRME (Prime Medicine Inc) - Prakiraan volume dodolan|Taysha Gene Therapies, Inc. - Pendapatan sing dikarepake perusahaan|Prakiraan volume dodolan QURE|MGTX: Pendapatan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan REGENXBIO RGNX|SLDB: Prakiraan pendapatan perusahaan|OCGN: Volume dodolan mangsa ngarep perusahaan|PACB - Prakiraan volume dodolan|BNTC (Benitec Corp) - Volume dodolan mangsa ngarep perusahaan|Prakiraan dodolan perusahaan Design Corp DSGN|Prakiraan pendapatan perusahaan Rocket Pharmaceuticals|Prakiraan volume dodolan 4D Molecular Therapeutics, Inc.|Prakiraan pendapatan perusahaan Lexeo (LXEO)|KRRO (Korro Bio Inc.) - Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan EDIT (Editas Medicine, Inc.)|Prakiraan volume dodolan Silence Therapeutics Corp SLN|PRQR - Prakiraan pendapatan perusahaan|Dodolan mangsa ngarep perusahaan Codexis Inc CDXS|SGMO: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan NAUT|Prakiraan pendapatan perusahaan metagenomi.co|Prakiraan volume dodolan Precision BioSciences Inc.|Prakiraan volume dodolan GBIO|Boundless Bio, Inc. - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan XCUR (Exicure, Inc.)|Dodolan mangsa ngarep perusahaan Imunon, Inc. (IMNN)|MBIO: Volume dodolan mangsa ngarep perusahaan|Pendapatan mangsa ngarep perusahaan RNAZ (transcodetherapeutics.com)|Bionano Genomics, Inc. (BNGO) - Prakiraan pendapatan perusahaan|APDN - Dodolan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan BLUE|Prakiraan volume dodolan immunoprecise.com|Prakiraan volume dodolan OMGA|Dodolan mangsa ngarep perusahaan Singular Genomics Corp|Regulus Therapeutics - Volume dodolan mangsa ngarep perusahaan|SYRS (Syros Pharmaceuticals) - Pendapatan sing dikarepake perusahaan|Telesis Bio Inc. - Prakiraan volume dodolan|Pendapatan mangsa ngarep perusahaan TCON (TRACON Pharmaceuticals Inc.)|UBX: Prakiraan volume dodolan